Produktname:1-(1,1-Dimethylethyl) 5-(2,5-dioxo-1-pyrrolidinyl) N-[16-(1,1-dimethylethoxy)-1,16-dioxohexadecyl]-L-glutamate
IUPAC Name:1-tert-butyl 2,5-dioxopyrrolidin-1-yl (2R)-2-[16-(tert-butoxy)-16-oxohexadecanamido]pentanedioate
- CAS:843666-26-2
- Molekulare Formel:C33H56N2O9
- Reinheit:99% HPLC
- Katalognummer:CM1075332
- Molekulargewicht:624.82
Packungseinheit |
Verfügbarer Vorrat |
Preis($) |
Menge |
Nur für den Einsatz in Forschung und Entwicklung..
Produkt-Details
- CAS-Nr.:843666-26-2
- Molekulare Formel:C33H56N2O9
- Schmelzpunkt:-
- SMILES-Code:CC(C)(C)OC(=O)CCCCCCCCCCCCCCC(=O)N[C@H](CCC(=O)ON1C(=O)CCC1=O)C(=O)OC(C)(C)C
- Dichte:
- Katalognummer:CM1075332
- Molekulargewicht:624.82
- Siedepunkt:
- Mdl-Nr.:
- Lagerung:
Category Infos
- Fatty Acid Modified Side Chains
- Fatty acid-modified side chains are small molecule modifiers and are one of the important factors that change the pharmacokinetic behavior of insulin products. Peptide drugs have the problem of short half-life and easy degradation in clinical practice. Introducing fatty acid-modified side chains into peptide drugs can increase the hydrophobicity of the drug and increase the biological half-life, thereby reducing the dosage and frequency of medication.